机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China[2]Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China[4]National Clinical Research Center for Geriatric Disorders, Changsha, China[5]Key Laboratory of Translational Radiation Oncology, Hunan Province, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China[6]Department of Laboratory Medicine, National Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院
Innovation Driven Project of Central
South University, Grant/Award Number:
2016CX024; National Key Research and
Development Program,
Grant/Award Numbers:
2016YFC0905000, 2016YFC0905001;
National Natural Science Foundation of
China, Grant/Award Numbers: 81472802,
81522048, 81573511, 81874329
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|3 区生物学
小类|3 区生化与分子生物学3 区细胞生物学
最新[2023]版:
大类|3 区生物学
小类|3 区生化与分子生物学4 区细胞生物学
第一作者:
第一作者机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China[2]Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China[4]National Clinical Research Center for Geriatric Disorders, Changsha, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China[2]Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China[3]Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China[4]National Clinical Research Center for Geriatric Disorders, Changsha, China[5]Key Laboratory of Translational Radiation Oncology, Hunan Province, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China[*1]Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008 Hunan, China.[*2]Key Laboratory of Translational Radiation Oncology, Hunan Province,Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013 Hunan, China.
推荐引用方式(GB/T 7714):
Zhen Guo,Youhong Wang,Yu Zhao,et al.A functional variant in CHK1 contributes to increased risk of nasopharyngeal carcinoma in a Han Chinese population.[J].Journal of cellular biochemistry.2020,121(5-6):3248-3255.doi:10.1002/jcb.29592.
APA:
Zhen Guo,Youhong Wang,Yu Zhao,Yi Jin,Liang An...&Wei Zhang.(2020).A functional variant in CHK1 contributes to increased risk of nasopharyngeal carcinoma in a Han Chinese population..Journal of cellular biochemistry,121,(5-6)
MLA:
Zhen Guo,et al."A functional variant in CHK1 contributes to increased risk of nasopharyngeal carcinoma in a Han Chinese population.".Journal of cellular biochemistry 121..5-6(2020):3248-3255